How Status Quo Can Change! First, troubles in/with Philippines... Now, it's El Salvador... Time to take stock. To re-evaluate. DYOR
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling